3D bioprinted aged human post‐infarct myocardium tissue model
Health Science Reports · 2024-04 · 7 (4)
DOI: 10.1002/hsr2.1945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 22.04.2024. Verfasst von Gozde Basara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aerospace and Mechanical Engineering University of Notre Dame Notre Dame Indiana USA. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health, National Science Foundation.
Abstract (Originalsprache)
Background and Aims Fibrotic tissue formed after myocardial infarction (MI) can be as detrimental as MI itself. However, current in vitro cardiac fibrosis models fail to recapitulate the complexities of post‐MI tissue. Moreover, although MI and subsequent fibrosis is most prominent in the aged population, the field suffers from inadequate aged tissue models. Herein, an aged human post‐MI tissue model, representing the native microenvironment weeks after initial infarction, is engineered using three‐dimensional bioprinting via creation of individual bioinks to specifically mimic three distinct regions: remote, border, and scar.
Methods
The aged post‐MI tissue model is engineered through combination of gelatin methacryloyl, methacrylated hyaluronic acid, aged type I collagen, and photoinitiator at variable concentrations with different cell types, including aged human induced pluripotent stem cell‐derived cardiomyocytes, endothelial cells, cardiac fibroblasts, and cardiac myofibroblasts, by introducing a methodology which utilizes three printheads of the bioprinter to model aged myocardium. Then, using cell‐specific proteins, the cell types that comprised each region are confirmed using immunofluorescence. Next, the beating characteristics are analyzed. Finally, the engineered aged post‐MI tissue model is used as a benchtop platform to assess the therapeutic effects of stem cell‐derived extracellular vesicles on the scar region.
Results
As a result, high viability (>74%) was observed in each region of the printed model. Constructs demonstrated functional behavior, exhibiting a beating velocity of 6.7 μm/s and a frequency of 0.3 Hz. Finally, the effectiveness of hiPSC‐EV and MSC‐EV treatment was assessed. While hiPSC‐EV treatment showed no significant changes, MSC‐EV treatment notably increased cardiomyocyte beating velocity, frequency, and confluency, suggesting a regenerative potential.
Conclusion
In conclusion, we envision that our approach of modeling post‐MI aged myocardium utilizing three printheads of the bioprinter may be utilized for various applications in aged cardiac microenvironment modeling and testing novel therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Aerospace and Mechanical Engineering University of Notre Dame Notre Dame Indiana USA.
- Bioengineering Graduate Program University of Notre Dame Notre Dame Indiana USA.
- Department of Mathematics University of Notre Dame Notre Dame Indiana USA.
- Department of Chemical and Biomolecular Engineering University of Notre Dame Notre Dame Indiana USA.
- Harper Cancer Research Institute University of Notre Dame Notre Dame Indiana USA.
ORCID-Profile: Pinar Zorlutuna
Förderung
- NHLBI NIH HHS
- National Institutes of Health
- National Science Foundation
Zitieren
APA
Basara, G., Celebi, L. E., Ronan, G., Discua Santos, V., & Zorlutuna, P. (2024). 3D bioprinted aged human post‐infarct myocardium tissue model. Health Science Reports, 7(4). https://doi.org/10.1002/hsr2.1945
Vancouver
Basara G, Celebi LE, Ronan G, Discua Santos V, Zorlutuna P. 3D bioprinted aged human post‐infarct myocardium tissue model. Health Science Reports. 2024;7(4). doi:10.1002/hsr2.1945
BibTeX
@article{Basara2024,
author = {Basara, Gozde and Celebi, Lara Ece and Ronan, George and Discua Santos, Victoria and Zorlutuna, Pinar},
title = {3D bioprinted aged human post‐infarct myocardium tissue model},
journal = {Health Science Reports},
year = {2024},
volume = {7},
number = {4},
doi = {10.1002/hsr2.1945}
}
EUVIMED